Dr. Eric D. Adler, M.D
Heart Failure & Transplant Cardiology (Advanced Heart Failure and Transplant Cardiology Physician)
200 W Arbor Dr
San Diego, CA 92103
Who else practices at this address →
San Diego County includes primary care (1% of residents) and mental health (1% of residents) shortage areas. About shortage areas
- Medicare participating
At a glance
- Medical school
- Boston University School of Medicine (2000)
- Years since graduation
- 26
- In the NPI registry since
- 2007
- Medicare patients seen, 2024
- 152
Licensed in California since 2011, according to the Medical Board of California. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2000Medical school: Boston University School of Medicine
- 2007Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Advanced Heart Failure and Transplant Cardiology Physician primary
CA license A116525 (first issued 2011; current) -
Cardiovascular Disease Physician
CA license A116525 (first issued 2011; current)
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Map: Heart Failure & Transplant Cardiology per capita by county →
Where they work
Hospitals
- UC San Diego Health Hillcrest - Hillcrest Med Ctr San Diego, CA
Medical groups
- Regents of the University of California (2,089 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 152
- Services billed
- 449
- Patients’ average age
- 71
| Service | Times | Patients |
|---|---|---|
| Established patient office or other outpatient visit, 30-39 minutes | 117 | 86 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 111 | 45 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 56 | 34 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 22 | 22 |
| Established patient office or other outpatient visit, 20-29 minutes | 17 | 14 |
| Influenza vaccine split virus, preservative free | 11 | 11 |
| Administration of influenza virus vaccine | 11 | 11 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Jardiance (empagliflozin) Other prescribers in San Diego, CA | 112 |
| Spironolactone Other prescribers in San Diego, CA | 91 |
| Entresto (sacubitril/valsartan) Other prescribers in San Diego, CA | 80 |
| Carvedilol Other prescribers in San Diego, CA | 58 |
| Metoprolol Succinate Other prescribers in San Diego, CA | 57 |
| Rosuvastatin Calcium Other prescribers in San Diego, CA | 44 |
| Atorvastatin Calcium Other prescribers in San Diego, CA | 40 |
| Farxiga (dapagliflozin propanediol) Other prescribers in San Diego, CA | 39 |
| Potassium Chloride Other prescribers in San Diego, CA | 37 |
| Vyndaqel (tafamidis meglumine) | 34 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 6 companies reported 11 payments worth $1,024 in total to this clinician.
| Abiomed | $411 |
|---|---|
| Abbott Laboratories | $233 |
| Philips North America LLC | $150 |
| Edwards Lifesciences Corporation | $141 |
| Kestra Medical Technology Services, Inc. | $57.07 |
| Novo Nordisk Inc | $31.94 |
| Food and Beverage | $1,024 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 5 industry-funded studies in 2025, from 2 companies. The companies reported $286,852 in research payments for these studies, mostly to the institutions running them.
- Expanded Access Protocol to Provide Patisiran to Patients With Transthyretin-mediated Amyloidosis (ATTR Amyloidosis) With Cardiomyopathy
Alnylam Pharmaceuticals Inc. - A Randomized, Double-blind, Placebo-controlled Clinical Study to Evaluate Mavacamten in Adults with Symptomatic Non-obstructive Hypertrophic Cardiomyopathy
E.r. Squibb & Sons, L.l.c. - An Open-Label Extension Study to Assess the Safety and Efficacy of Vutrisiran in Patients with Transthyretin Amyloidosis with Cardiomyopathy (ATTR Amyloidosis with Cardiomyopathy)
Alnylam Pharmaceuticals Inc. - A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-2)
E.r. Squibb & Sons, L.l.c. · Recruiting · NCT06951711 - A Study to Assess the Long-term Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-3)
E.r. Squibb & Sons, L.l.c. · Recruiting · NCT06929273
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.